Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports | Annals of Internal Medicine

Background: In December 2020, the U.S. Food and Drug Administration issued an emergency use authorization for the Pfizer-BioNTech and Moderna messenger RNA vaccines for

Annals of Int Med

Authors in Annals report using graded doses to successfully administer a second dose of the #Moderna vaccine to 2 patients who had an immediate hypersensitivity reaction with the 1st dose. Text freely available at https://t.co/iBNZRgaU0F. #COVID19 https://t.co/iBNZRgaU0F. - view on twitter

More coverage: #covid19 #Moderna

Read the full article here

See more from Annals of Int Med